Sinclair becomes pure-play aesthetics
Shares in Sinclair IS Pharma (SPH:AIM) shot up 8% to 38.6p in early trading after the skin care specialist sold a non-core business for more than half the group's market cap.The non-aesthetics products and brands have been sold to...
26 November 2015
